Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BLL003
MIFTS: 53

Bell's Palsy

Categories: Eye diseases, Infectious diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bell's Palsy

About this section

MalaCards integrated aliases for Bell's Palsy:

Name: Bell's Palsy 12 77 54 55 44 15 17
Bell Palsy 12 54 45 74
Facial Paralysis 54 74
Facial Cranial Nerve Paralysis 54
Idiopathic Facial Palsy 54
Refrigeration Palsy 54
Facial Nerve Palsy 54
Bell's Palsy 12
Antoni's Palsy 54
Facial Palsy 54

Classifications:

MalaCards categories:
Global: Rare diseases Infectious diseases
Anatomical: Neuronal diseases Eye diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:12506
ICD9CM 36 351.0
MeSH 45 D020330
SNOMED-CT 69 79359001
ICD10 34 G51.0
Sources

Summaries for Bell's Palsy

About this section
NINDS : 55 Bell's palsy is a form of temporary facial paralysis resulting from damage or trauma to the 7th cranial nerve, one of the facial nerves. It is the most common cause of facial paralysis. Generally, Bell's palsy affects only one side of the face, but it can affect both sides. Symptoms vary among individuals and include sudden weakness on one side of the face, drooping eyelid or corner of the mouth, drooling, inability to close the eye or mouth, altered taste, and excessive tearing in the eye. Symptoms appear suddenly and reach their peak within 72 hours. Bell's palsy can range in severity from mild weakness to total paralysis, and can cause significant facial distortion. The exact cause of Bell's palsy isn't known, but many scientists believe that reactivation of a dormant viral infection can cause the facial nerve to swell and become inflamed. Several other conditions can cause facial paralysis that might be diagnosed as Bell's palsy. The disorder can affect anyone at any age. Risk factors include pregnancy, preeclampsia, obesity, hypertention, diabetes, and upper respiratory ailments.

MalaCards based summary : Bell's Palsy, also known as bell palsy, is related to facial paralysis and essential tremor, and has symptoms including seizures, muscle weakness and tremor. An important gene associated with Bell's Palsy is HS1BP3 (HCLS1 Binding Protein 3). The drugs Prednisolone phosphate and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and bone.

Disease Ontology : 12 A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).

NIH Rare Diseases : 54 Bell's palsy is a form of temporary facial paralysis which results from damage or trauma to one of the facial nerves. This disorder is characterized by the sudden onset of facial paralysis that often affects just one side and can cause significant facial distortion. Symptoms vary, but may include twitching, weakness, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, impairment of taste, and excessive tearing in the eye. While the exact cause is unknown, many researchers believe that a virus may lead to swelling of the 7th cranial nerve. Steroids, such as prednisone, may reduce the inflammation and swelling. Other medications used to treat Bell's palsy include acyclovir (to fight viral infections) and aspirin, acetaminophen, or ibuprofen (to relieve pain).Physical therapy, facial massage and acupuncture have also been used.

MedlinePlus : 44 Bell's palsy is the most common cause of facial paralysis. It usually affects just one side of the face. Symptoms appear suddenly and are at their worst about 48 hours after they start. They can range from mild to severe and include Twitching Weakness Paralysis Drooping eyelid or corner of mouth Drooling Dry eye or mouth Excessive tearing in the eye Impaired ability to taste Scientists think that a viral infection makes the facial nerve swell or become inflamed. You are most likely to get Bell's palsy if you are pregnant, diabetic or sick with a cold or flu. Three out of four patients improve without treatment. With or without treatment, most people begin to get better within 2 weeks and recover completely within 3 to 6 months. NIH: National Institute of Neurological Disorders and Stroke

Wikipedia : 77 Bell''s palsy is a type of facial paralysis that results in an inability to control the facial muscles... more...

Sources

Related Diseases for Bell's Palsy

About this section

Diseases related to Bell's Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 402)
# Related Disease Score Top Affiliating Genes
1 facial paralysis 30.8 HOXB1 LIPN
2 essential tremor 29.6 HS1BP3 PRKN
3 facial palsy, congenital, with ptosis and velopharyngeal dysfunction 12.6
4 recurrent peripheral facial palsy 12.3
5 congenital hereditary facial paralysis-variable hearing loss syndrome 12.2
6 deafness, conductive stapedial, with ear malformation and facial palsy 12.2
7 aortic arch interruption, facial palsy, and retinal coloboma 12.1
8 anotia facial palsy cardiac defect 12.1
9 facial palsy, familial recurrent peripheral 11.7
10 lyme disease 11.6
11 urofacial syndrome 1 11.5
12 facial paresis, hereditary congenital, 3 11.4
13 lyme disease - neurological complications 11.3
14 carey-fineman-ziter syndrome 11.2
15 facial paresis, hereditary congenital, 1 11.1
16 craniometaphyseal dysplasia, autosomal dominant 11.1
17 craniometaphyseal dysplasia, autosomal recessive 11.1
18 sclerosteosis 1 11.1
19 sclerosteosis 2 11.1
20 orofacial granulomatosis 11.1
21 familial amyloidosis, finnish type 11.1
22 osteopetrosis, autosomal recessive 1 11.0
23 osteopathia striata with cranial sclerosis 11.0
24 thiamine metabolism dysfunction syndrome 2 11.0
25 lethal congenital contracture syndrome 2 11.0
26 sclerosteosis 11.0
27 biotin-thiamine-responsive basal ganglia disease 11.0
28 amyloidosis, finnish type 10.9
29 camurati-engelmann disease 10.9
30 pontine tegmental cap dysplasia 10.9
31 charlie m syndrome 10.9
32 herpes simplex 10.6
33 diabetes mellitus 10.5
34 myoclonus and ataxia 10.5
35 hepatitis 10.4
36 herpes zoster 10.3
37 neuropathy 10.3
38 hemifacial spasm 10.3
39 influenza 10.3
40 pfeiffer syndrome 10.3
41 blepharospasm 10.3
42 pre-eclampsia 10.2
43 eclampsia 10.2
44 polyneuropathy 10.2
45 chickenpox 10.2
46 geniculate herpes zoster 10.2
47 bone fracture 10.2
48 neuroma 10.2
49 meniere disease 10.2
50 hepatitis b 10.2

Graphical network of the top 20 diseases related to Bell's Palsy:



Diseases related to Bell's Palsy
Sources

Symptoms & Phenotypes for Bell's Palsy

About this section

UMLS symptoms related to Bell's Palsy:


seizures, muscle weakness, tremor, generalized muscle weakness, back pain, ophthalmoplegia, pain, headache, hemiplegia, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness, oral manifestations, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, flaccid muscle tone
Sources

Drugs & Therapeutics for Bell's Palsy

About this section

Drugs for Bell's Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 117)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 302-25-0
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-24-8 5755
3
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Not Applicable 2921-57-5
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 83-43-2 6741
5
Acetylcholine Approved, Investigational Phase 4,Not Applicable 51-84-3 187
6
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
7
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Not Applicable 2920-86-7
8
Cortisone Experimental Phase 4 53-06-5 222786
9 Autonomic Agents Phase 4,Phase 3,Phase 2,Not Applicable
10 Protective Agents Phase 4,Phase 3,Not Applicable
11 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
12 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable
13 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Not Applicable
14 Antiemetics Phase 4,Phase 3,Phase 2,Not Applicable
15 Methylprednisolone Acetate Phase 4,Phase 3,Phase 2,Not Applicable
16 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Not Applicable
17 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
18 Prednisolone acetate Phase 4,Phase 3,Phase 2,Not Applicable
19 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
20 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
21 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Neuroprotective Agents Phase 4,Phase 3,Not Applicable
23 Antiviral Agents Phase 4,Not Applicable,Early Phase 1
24 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
25 valacyclovir Phase 4,Not Applicable
26 Neurotransmitter Agents Phase 4,Not Applicable
27 incobotulinumtoxinA Phase 4
28 Botulinum Toxins Phase 4,Not Applicable
29 Botulinum Toxins, Type A Phase 4,Not Applicable
30 Neuromuscular Agents Phase 4,Not Applicable
31 Acetylcholine Release Inhibitors Phase 4,Not Applicable
32 abobotulinumtoxinA Phase 4,Not Applicable
33 Cholinergic Agents Phase 4,Not Applicable
34 Immunologic Factors Phase 4,Phase 3
35 Vaccines Phase 4,Phase 3,Phase 2
36 Anesthetics Phase 4,Phase 3,Phase 2,Not Applicable
37 Anti-Arrhythmia Agents Phase 4,Phase 3,Not Applicable
38 Sodium Channel Blockers Phase 4,Not Applicable
39 Anesthetics, Local Phase 4,Not Applicable
40 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
41 Diuretics, Potassium Sparing Phase 4,Not Applicable
42
Prednisone Approved, Vet_approved Phase 2, Phase 3,Not Applicable,Early Phase 1 53-03-2 5865
43
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
44
Nicardipine Approved, Investigational Phase 3,Phase 1 55985-32-5 4474
45
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3,Not Applicable 50-02-2 5743
46
Benzocaine Approved, Investigational Phase 2, Phase 3,Phase 3 1994-09-7, 94-09-7 2337
47
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
48
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3,Not Applicable 1177-87-3
49
tannic acid Approved Phase 2, Phase 3,Phase 3 1401-55-4
50
Labetalol Approved Phase 3 36894-69-6 3869

Interventional clinical trials:

(show top 50) (show all 89)
# Name Status NCT ID Phase Drugs
1 Scandinavian Bell's Palsy Study Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
3 A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults Completed NCT01427309 Phase 4
4 Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy Recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
5 Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
6 Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery Completed NCT00438087 Phase 3 methylprednisolone
7 Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 Completed NCT01604746 Phase 3
8 Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial Completed NCT00059332 Phase 3 Magnesium Sulfate;Normal Saline
9 A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis Completed NCT02020889 Phase 3 Placebo
10 Intratympanic Steroid for Bell's Palsy Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
11 Neuroprotectant for Hypertensive Intracerebral Hemorrhage Not yet recruiting NCT03546283 Phase 3 Placebos;Cattle Encephalon Glycoside and Ignotin
12 Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older Terminated NCT00976027 Phase 3
13 Antihypertensive Treatment of Acute Cerebral Hemorrhage-II Terminated NCT01176565 Phase 3 Intravenous nicardipine hydrochloride
14 Quadrant Versus Superficial Parotidectomy Withdrawn NCT01607866 Phase 2, Phase 3
15 Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study Withdrawn NCT01614977 Phase 3 Methylprednisoline
16 Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children Completed NCT01777633 Phase 1, Phase 2
17 Seasonal Flu Vaccine in Adult Transplant Recipients Completed NCT01258023 Phase 2
18 Contrastim Stroke Trial Completed NCT01049802 Phase 1, Phase 2
19 A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma Completed NCT01153763 Phase 2 GSK2118436
20 A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Recruiting NCT02785120 Phase 2 TF0023
21 Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke Not yet recruiting NCT03763929 Phase 2 Trans-Sodium Crocetinate
22 Activated Protein C in Acute Stroke Trial Terminated NCT00533546 Phase 2 Activated Protein C
23 Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Terminated NCT01127503 Phase 2 Metyrosine;Placebo
24 Antihypertensive Treatment in Acute Cerebral Hemorrhage Completed NCT00415610 Phase 1 nicardipine
25 The Relationship Between Psychological Factors and Bell's Palsy Unknown status NCT01377766
26 Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China Unknown status NCT01201642 Not Applicable Prednisolone
27 Quantification, Analysis and Simulation of Facial Mimics Movements Unknown status NCT02002572 Not Applicable
28 Two Different Surgical Methods of Blepharospasm Unknown status NCT02765113 Early Phase 1
29 R. I. S. POS. T. A Unknown status NCT01991665 Not Applicable
30 Comparing the Behavior of the Cardiac Autonomic Regulation System During 24h in Patient Post Stroke and Controls Unknown status NCT02735616
31 A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy Completed NCT01686464 Not Applicable prednisone and valacyclovir treatments
32 Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages Completed NCT00608660 Not Applicable
33 Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy Completed NCT00685789 Not Applicable
34 Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy Completed NCT00561106 Not Applicable prednisone- valacyclovir;prednisone-placebo
35 Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy Completed NCT02328079 Not Applicable Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
36 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
37 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
38 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
39 Myofunctional Therapy in Facial Palsy Completed NCT00989209 Not Applicable Botulinum Toxin Type A
40 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis Completed NCT01327157 Not Applicable
41 Cognitive Function and Emotional Possessing in Bilateral Facial Palsy Completed NCT02179450
42 The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis Patients Completed NCT02489162 Not Applicable
43 Complications in Parotid Surgery Completed NCT02486393
44 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
45 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226 Not Applicable
46 The Prehospital Selection of Acute Stroke Patients Completed NCT03072524
47 Magnetic Correction of Eye Lid Paralysis Completed NCT02988856 Not Applicable
48 Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Completed NCT01985997
49 Clinical Research Core Dental Screening Protocol Completed NCT00090818
50 National Prospective and Comparative Study on the Mode of Delivery of Twins Completed NCT01987063

Search NIH Clinical Center for Bell's Palsy

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: bell palsy

Sources

Genetic Tests for Bell's Palsy

About this section
Sources

Anatomical Context for Bell's Palsy

About this section

MalaCards organs/tissues related to Bell's Palsy:

42
Eye, Testes, Bone, Tongue, Myeloid, Kidney, Neutrophil
Sources

Publications for Bell's Palsy

About this section

Articles related to Bell's Palsy:

(show top 50) (show all 1350)
# Title Authors Year
1
Antivirals With Corticosteroids for the Treatment of Acute Bell's Palsy. ( 30182458 )
2019
2
Computer vision technology-based face mirroring system providing mirror therapy for Bell's palsy patients. ( 30634878 )
2019
3
Neonatal Bell's Palsy and Possible Correlation with Human Leukocyte Antigens. ( 30671192 )
2019
4
Letter in Reply: "Neonatal Bell's Palsy and Possible Correlation with Human Leukocyte Antigens". ( 30671193 )
2019
5
Recurrent Bell's palsy. ( 30672667 )
2019
6
Comparative prognosis in patients with Ramsay-Hunt syndrome and Bell's palsy. ( 30707280 )
2019
7
Does Herpes 6 Infection have a Role in Bell's Palsy Among Children and Adolescents? ( 30724837 )
2019
8
Clinical efficacy and safety of thread-embedding acupuncture for treatment of the sequelae of Bell's palsy: A protocol for a patient-assessor blinded, randomized, controlled, parallel clinical trial. ( 30762782 )
2019
9
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Hematologic Markers of Bell's Palsy: A Meta-analysis. ( 30807521 )
2019
10
Morphometric analysis of CT scans of the facial canal in Bell's palsy: a study of 51 patients. ( 30888701 )
2019
11
Bell's palsy and Guillain-Barré syndrome may be two ends of the same spectrum. ( 30908681 )
2019
12
The etiology of Bell's palsy: a review. ( 30923934 )
2019
13
Increased risk of depression in Bell's palsy: Two longitudinal follow-up studies using a national sample cohort. ( 30933749 )
2019
14
The Efficacy of Acupuncture in the Treatment of Bell's Palsy Sequelae. ( 30946987 )
2019
15
Efficacy of laser acupuncture for patients with chronic Bell's palsy: A study protocol for a randomized, double-blind, sham-controlled pilot trial. ( 30985671 )
2019
16
50 Years Ago in The Journal of Pediatrics: Comments on Current Literature: Bell's Palsy in Children. ( 31027621 )
2019
17
Differences in functional brain alterations driven by right or left facial nerve efferent dysfunction: Evidence from early Bell's palsy. ( 31032190 )
2019
18
Neural mobilization in Bell's palsy: A case report. ( 31043132 )
2019
19
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Hematologic Markers of Bell's Palsy: A Meta-analysis. ( 31083100 )
2019
20
Compare the efficacy of acupuncture with drugs in the treatment of Bell's palsy: A systematic review and meta-analysis of RCTs. ( 31083225 )
2019
21
Course of Concomitant Bell's Palsy and Trigeminal Neuralgia Shortened with a Multi-Modal Intervention: A Case Report. ( 31104906 )
2019
22
Bell Palsy and the Risk of Cardio-Cerebrovascular Disease: A Population-Based Follow-Up Study. ( 30632167 )
2019
23
A study of affecting the recovery of Chinese patients with Bell palsy. ( 30681613 )
2019
24
Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report. ( 28926356 )
2018
25
High-dose corticosteroids improve the prognosis of Bell's palsy compared with low-dose corticosteroids: A propensity score analysis. ( 28947095 )
2018
26
A Case of Bell's Palsy Complicated by Subsequent Herpes Simplex Virus Encephalitis. ( 29144221 )
2018
27
Prevalence and characteristics of hearing loss in patients diagnosed with Bell's Palsy. ( 29164322 )
2018
28
Recurrent Bell's palsy following ventriculoperitoneal shunt insertion: an unusual case to face. ( 29191062 )
2018
29
Does Type 2 Diabetes Mellitus Affect the Healing of Bell's Palsy in Adults? ( 29284561 )
2018
30
Delayed facial nerve decompression for severe refractory cases of Bell's palsy: a 25-year experience. ( 29301560 )
2018
31
The effect of metabolic syndrome on Bell's palsy recovery rate. ( 29374993 )
2018
32
Prognostic value of the blink reflex test in Bell's palsy and Ramsay-Hunt syndrome. ( 29402606 )
2018
33
Pontine haemorrhage disguised as Bell's palsy. ( 29437741 )
2018
34
Idiopathic Non-traumatic Facial Nerve Palsy (Bell's Palsy) in Neonates; An Atypical Age and Management Dilemma. ( 29468002 )
2018
35
Prognostic role of neurophysiological testing 3-7 days after onset of acute unilateral Bell's palsy. ( 29496378 )
2018
36
A Case Report of a Child with Bell's Palsy. ( 29872589 )
2018
37
Augmentation effect of acupuncture on Bi'nao for hypophasis in patients with Bell's palsy: study protocol for a randomized controlled trial. ( 29891003 )
2018
38
Evaluation of the facial nerve and internal auditory canal cross-sectional areas on three-dimensional fast imaging employing steady-state acquisition magnetic resonance imaging in Bell’s palsy ( 29914247 )
2018
39
A Case of An Unusual Bell's Palsy Mimic. ( 29961527 )
2018
40
Increased incidence of Bell's palsy with worse outcomes in pregnancy. ( 30007744 )
2018
41
Evidence for Seasonal Variation of Bell's Palsy in Germany. ( 30092584 )
2018
42
Weather, Weather Changes and the Risk of Bell's Palsy: A Multicenter Case-Crossover Study. ( 30205396 )
2018
43
Bell's Palsy-Tertiary Ischemia: An Etiological Factor in Residual Facial Palsy. ( 30211092 )
2018
44
Bell's palsy treated with photobiomodulation in an adolescent: Rare case report and review of the published literature. ( 30218464 )
2018
45
Systematic Review of Facial Nerve Outcomes After Middle Fossa Decompression and Transmastoid Decompression for Bell's Palsy With Complete Facial Paralysis. ( 30239428 )
2018
46
Comparison of conservative therapy and steroid therapy for Bell's palsy in children. ( 30304913 )
2018
47
Radiation Exposure and Bell's Palsy: A Hypothetical Association. ( 30320038 )
2018
48
A report of Bell's Palsy triggered by leptomeningeal metastases from recurrent high grade serous ovarian cancer. ( 30417064 )
2018
49
Altered Brain Fraction Amplitude of Low Frequency Fluctuation at Resting State in Patients With Early Left and Right Bell's Palsy: Do They Have Differences? ( 30450029 )
2018
50
The Epidemiology and Management of Bell's Palsy in the Sudan. ( 30505363 )
2018
Sources

Variations for Bell's Palsy

About this section

ClinVar genetic disease variations for Bell's Palsy:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 46;XX;t(1;13)(q11.2;p11.2)dn Translocation Uncertain significance
Sources

Expression for Bell's Palsy

About this section
Search GEO for disease gene expression data for Bell's Palsy.
Sources

Pathways for Bell's Palsy

About this section
Sources

GO Terms for Bell's Palsy

About this section

Cellular components related to Bell's Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 azurophil granule lumen GO:0035578 8.62 DEFA1 DEFA3

Biological processes related to Bell's Palsy according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 defense response to Gram-positive bacterium GO:0050830 9.52 DEFA1 DEFA3
2 defense response to Gram-negative bacterium GO:0050829 9.51 DEFA1 DEFA3
3 defense response to virus GO:0051607 9.5 DEFA1 DEFA3 MX1
4 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.49 DEFA1 DEFA3
5 antimicrobial humoral response GO:0019730 9.48 DEFA1 DEFA3
6 killing of cells of other organism GO:0031640 9.46 DEFA1 DEFA3
7 antibacterial humoral response GO:0019731 9.43 DEFA1 DEFA3
8 defense response to fungus GO:0050832 9.4 DEFA1 DEFA3
9 innate immune response in mucosa GO:0002227 9.37 DEFA1 DEFA3
10 intracellular estrogen receptor signaling pathway GO:0030520 9.26 DEFA1 DEFA3
11 mitochondrial fission GO:0000266 9.16 MX1 PRKN
12 defense response GO:0006952 9.13 DEFA1 DEFA3 MX1
13 membrane disruption in other organism GO:0051673 8.62 DEFA1 DEFA3
Sources

Sources for Bell's Palsy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....